Transfusion-Associated Graft-Versus-Host Disease in Adults.
Elmakki EE, Madkhali MA, Oraibi O, Alqassimi S, Saleh E.
Cureus. 2023 Aug 26;15(8):e44148. doi: 10.7759/cureus.44148. eCollection 2023 Aug.
Transfusion-associated graft-versus-host disease.
Dwyre DM, Holland PV.
Vox Sang. 2008 Aug;95(2):85-93. doi: 10.1111/j.1423-0410.2008.01073.x. Epub 2008 Jun 9.
Can transfusion-associated graft-versus-host disease (TA-GvHD) be prevented with leukoreduction alone?
Rodriguez JV, Tormey CA.
Transfus Apher Sci. 2022 Apr;61(2):103402. doi: 10.1016/j.transci.2022.103402. Epub 2022 Mar 11.
Transfusion-associated graft-versus-host disease.
Rühl H, Bein G, Sachs UJ.
Transfus Med Rev. 2009 Jan;23(1):62-71. doi: 10.1016/j.tmrv.2008.09.006.
How does transfusion-associated graft-versus-host disease compare to hematopoietic cell transplantation-associated graft-versus-host disease?
Aizawa K, Peltier D, Matsuki E, Toubai T.
Transfus Apher Sci. 2022 Apr;61(2):103405. doi: 10.1016/j.transci.2022.103405. Epub 2022 Feb 17.
Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem.
Jawa RS, Young DH, Stothert JC, Kulaylat MN, Landmark JD.
J Intensive Care Med. 2015 Mar;30(3):123-30. doi: 10.1177/0885066613492645. Epub 2013 Jun 20.
How is transfusion-associated graft-versus-host disease similar to, yet different from, organ transplantation-associated graft-versus-host disease?
Sato N, Marubashi S.
Transfus Apher Sci. 2022 Apr;61(2):103406. doi: 10.1016/j.transci.2022.103406. Epub 2022 Mar 10.
Transfusion-associated graft-versus-host disease.
Orlin JB, Ellis MH.
Curr Opin Hematol. 1997 Nov;4(6):442-8. doi: 10.1097/00062752-199704060-00015.
Transfusion-associated graft-versus-host disease.
Rappeport JM.
Yale J Biol Med. 1990 Sep-Oct;63(5):445-54.
Transfusion-associated graft versus host disease (TAGVHD)--with reference to neonatal period.
Gokhale SG, Gokhale SS.
J Matern Fetal Neonatal Med. 2015 Apr;28(6):700-4. doi: 10.3109/14767058.2014.928859. Epub 2014 Jul 1.
